Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
NASDAQ:MREO
Price:
0.3366
USD
3.16%
Market Closed
Market Cap:
$53.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
UK |
Balance Sheet
Balance Sheet Decomposition
Mereo Biopharma Group PLC
Mereo Biopharma Group PLC
Balance Sheet Decomposition is not available for
Mereo Biopharma Group PLC
Mereo Biopharma Group PLC
Balance Sheet
Mereo Biopharma Group PLC
Mereo Biopharma Group PLC
Currency: GBP
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
22
|
32
|
128
|
68
|
57
|
70
|
|
| Cash |
21
|
31
|
0
|
6
|
0
|
0
|
|
| Cash Equivalents |
1
|
1
|
128
|
62
|
57
|
70
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
16
|
6
|
3
|
3
|
3
|
1
|
|
| Other Current Assets |
3
|
2
|
4
|
4
|
4
|
3
|
|
| Total Current Assets |
40
|
41
|
134
|
75
|
64
|
75
|
|
| PP&E Net |
15
|
2
|
3
|
2
|
2
|
1
|
|
| PP&E Gross |
15
|
2
|
0
|
2
|
2
|
1
|
|
| Accumulated Depreciation |
2
|
2
|
0
|
2
|
1
|
1
|
|
| Intangible Assets |
59
|
43
|
27
|
29
|
1
|
1
|
|
| Total Assets |
115
N/A
|
86
-25%
|
165
+92%
|
107
-35%
|
66
-38%
|
76
+15%
|
|
| Liabilities | |||||||
| Accounts Payable |
8
|
4
|
3
|
3
|
2
|
2
|
|
| Accrued Liabilities |
7
|
6
|
5
|
5
|
6
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
24
|
1
|
1
|
14
|
0
|
6
|
|
| Other Current Liabilities |
1
|
1
|
4
|
7
|
1
|
1
|
|
| Total Current Liabilities |
40
|
12
|
13
|
30
|
9
|
14
|
|
| Long-Term Debt |
19
|
24
|
22
|
1
|
4
|
0
|
|
| Other Liabilities |
2
|
71
|
11
|
0
|
2
|
2
|
|
| Total Liabilities |
61
N/A
|
107
+74%
|
46
-56%
|
32
-32%
|
16
-50%
|
15
-3%
|
|
| Equity | |||||||
| Common Stock |
0
|
1
|
2
|
2
|
3
|
3
|
|
| Retained Earnings |
106
|
288
|
216
|
231
|
420
|
463
|
|
| Additional Paid In Capital |
161
|
221
|
335
|
308
|
486
|
540
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Equity |
2
|
45
|
2
|
4
|
17
|
19
|
|
| Total Equity |
53
N/A
|
20
N/A
|
119
N/A
|
75
-37%
|
51
-32%
|
61
+21%
|
|
| Total Liabilities & Equity |
115
N/A
|
86
-25%
|
165
+92%
|
107
-35%
|
66
-38%
|
76
+15%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
98
|
339
|
585
|
625
|
701
|
776
|
|
Switch to:
Switch to:
See Also
Discover More
